Upon completion of this activity, participants should be able to:
- Explain the rationale behind the development of next generation pneumococcal conjugate vaccines
- Identify highest-risk groups who should receive PCV15 versus PCV20
- Formulate strategies to engage patients in shared clinical decision-making per CDC recommendations